Literature DB >> 27142752

Synthesis and in vitro evaluation of (R), (S) and (R/S)-2-hexyne-1,4-diol, a natural product produced by fungus Clitocybe catinus, and related analogs as potential anticancer agents.

Iza Mirela R G Princival1, Jeiely G Ferreira2, Teresinha G Silva3, Jaciana S Aguiar3, Jefferson L Princival2.   

Abstract

The search for natural products and related analogs as potential anticancer agents has seen a significant growth worldwide. Since small sized propargylic diols can be found in nature and chemically synthesized, their evaluation against cancer cells has been of great interest, being a topic of relevance to be investigated. For this purpose, a scalable approach aiming at the synthesis of several propargylic diols and their bioactivity against seven tumor cell lines were evaluated. Interestingly, when the compound 1a, a natural product produced by fungus Clitocybe catinus, was tested in its racemic mixture a more effective activity was observed if compared when enantiopure R-1a or S-1a were tested separately.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioactive; Enantiomers; Propargylic; Synthesis; Tumor

Mesh:

Substances:

Year:  2016        PMID: 27142752     DOI: 10.1016/j.bmcl.2016.04.060

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents.

Authors:  Anne Cecília Nascimento da Cruz; Dalci José Brondani; Temístocles I Talo de Santana; Lucas Oliveira da Silva; Elizabeth Fernanda da Oliveira Borba; Antônio Rodolfo de Faria; Julianna Ferreira Cavalcanti de Albuquerque; Sylvie Piessard; Rafael Matos Ximenes; Blandine Baratte; Stéphane Bach; Sandrine Ruchaud; Francisco Jaime Bezerra Mendonça Junior; Marc-Antoine Bazin; Marcelo Montenegro Rabello; Marcelo Zaldini Hernandes; Pascal Marchand; Teresinha Gonçalves da Silva
Journal:  Pharmaceuticals (Basel)       Date:  2019-11-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.